NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sealantium Medical

Sealantium Medical

Private
IsraelHealthcare & Life Scienceshttps://sealantium-med.com/

Last Round

Grant

Apr 4, 2020

Total Funding Raised

$11.51M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Sealantium Medical is a biosurgery company that develops proprietary next-generation tissue sealants and hemostatic agents for patients undergoing surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hemostatic agentsurgical sealantbiosurgerybiodegradable polymerhemostasissurgical patchtissue sealingmedical devicefibrin sealantminimally invasive surgerybiomaterialssurgical bleeding controltrauma caresurgical gluewound closure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sealantium Medical Comparables

Compare Sealantium Medical with similar companies based on industry and business-model similarity.

Sealantium Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AsparaGlue
83%
Cresilon
78%
Medcura, Inc.
78%

Sealantium Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 4, 2020
Series BNov 14, 2017

Key People

Founding team and executive leadership

Chris Lamb

Co-Founder, CEO, Investor And Board Member

Founding Team

Orgad Laub

Founder And CEO

Founding Team

Sealantium Medical Investors

Notable investors and investment history

Sealantium Medical investors
InvestorRounds
European CommissionGrant
Biotech Alliances InternationalSeries B
AVV Investment GmbHSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 43% MoM.

  • May 18, 2026

    Monthly visitors increased 173% MoM.

Sealantium Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sealantium Medical Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersIsrael
Employee Range6
Year Founded2011
Last FundingApr 4, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.